Skip to main content
SpringerLink
Log in

Second-generation antipsychotics and the metabolic syndrome

  • Invited Commentary
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity: Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004, 27:596–601.

    Article  Google Scholar 

  2. Correll CU, Leucht S, Kane JM: Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 2004, 161:414–425.

    Article  PubMed  Google Scholar 

  3. Ryan MC, Collins P, Thakore JH: Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003, 160:284–289.

    Article  PubMed  Google Scholar 

  4. Wirshing DA, Pierre JM, Erhart SM, Boyd JA: Understanding the new and evolving profile of adverse drug effects in schizophrenia. Psychiatr Clin N Am 2003, 26:165–190.

    Article  Google Scholar 

  5. Newcomer JW, Nasrallah HA, Loebel AD: The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists. J Clin Psychopharmacol 2004, 24(Suppl 1):S1–6.

    Article  PubMed  Google Scholar 

  6. Nasrallah HA, Newcomer JW: Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. J Clin Psychopharmacol 2004, 24(Suppl 1):S7–14.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Duke University Medical Center, 110 Swift Avenue, Suite 1, 27705, Durham, NC, USA

    Prakash S. Masand MD

Authors
  1. Prakash S. Masand MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rajnish Mago MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Masand, P.S., Mago, R. Second-generation antipsychotics and the metabolic syndrome. Curr Psychiatry Rep 7, 153–154 (2005). https://doi.org/10.1007/s11920-005-0044-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-005-0044-1

Keywords

Search

Navigation